← Evidence map

ReviewExperimental hematology & oncology2020

CD44 as a tumor biomarker and therapeutic target.

Hanxiao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

208 papers cite itlatest 60 shown

2020
…
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33303029